Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Lakehal, F; Dansette, PM; Becquemont, L; Lasnier, E; Delelo, R; Balladur, P; Poupon, R; Beaune, PH; Housset, C
   Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes
   CHEMICAL RESEARCH IN TOXICOLOGY
   
   F. Lakehal et al., "Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes", CHEM RES T, 14(6), 2001, pp. 694-701
2. Poupon, R
   Overlap syndromes: autoimmune hepatitis - primary biliary cirrhosis; autoimmune hepatitis - primary sclerosing cholangitis
   PRESSE MEDICALE
   
   R. Poupon, "Overlap syndromes: autoimmune hepatitis - primary biliary cirrhosis; autoimmune hepatitis - primary sclerosing cholangitis", PRESSE MED, 30(1), 2001, pp. 25-27
3. Serfaty, L; Thabut, D; Zoulim, F; Andreani, T; Chazouilleres, O; Carbonell, N; Loria, A; Poupon, R
   Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: Results ofa pilot study
   HEPATOLOGY
   
   L. Serfaty et al., "Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: Results ofa pilot study", HEPATOLOGY, 34(3), 2001, pp. 573-577
4. Chignard, N; Mergey, M; Veissiere, D; Parc, R; Capeau, J; Poupon, R; Paul, A; Housset, C
   Bile acid transport and regulating functions in the human biliary epithelium
   HEPATOLOGY
   
   N. Chignard et al., "Bile acid transport and regulating functions in the human biliary epithelium", HEPATOLOGY, 33(3), 2001, pp. 496-503
5. Serfaty, L; Costagliola, D; Wendum, D; Picard, O; Meyohas, MC; Girard, PM; Lebas, J; Delamare, C; Poupon, R; Housset, C
   Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control study
   AIDS
   
   L. Serfaty et al., "Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control study", AIDS, 15(15), 2001, pp. 2011-2016
6. Corpechot, C; Benlian, P; Barbu, V; Chazouilleres, O; Poupon, RE; Poupon, R
   Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?
   JOURNAL OF HEPATOLOGY
   
   C. Corpechot et al., "Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?", J HEPATOL, 35(3), 2001, pp. 324-328
7. Serfaty, L; Andreani, T; Giral, P; Carbonell, N; Chazouilleres, O; Poupon, R
   Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C
   JOURNAL OF HEPATOLOGY
   
   L. Serfaty et al., "Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C", J HEPATOL, 34(3), 2001, pp. 428-434
8. Correia, L; Podevin, P; Borderie, D; Verthier, N; Montet, JC; Feldmann, G; Poupon, R; Weill, B; Calmus, Y
   Effects of bile acids on the humoral immune response - A mechanistic approach
   LIFE SCIENCES
   
   L. Correia et al., "Effects of bile acids on the humoral immune response - A mechanistic approach", LIFE SCI, 69(20), 2001, pp. 2337-2348
9. Rosmorduc, O; Hermelin, B; Poupon, R
   MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis
   GASTROENTEROLOGY
   
   O. Rosmorduc et al., "MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis", GASTROENTY, 120(6), 2001, pp. 1459-1467
10. Rosmorduc, O; Hermelin, B; Poupon, R
    Differential HFE allele expression in hemochromatosis heterozygotes - Reply
    GASTROENTEROLOGY
    
    O. Rosmorduc et al., "Differential HFE allele expression in hemochromatosis heterozygotes - Reply", GASTROENTY, 120(5), 2001, pp. 1308-1309
11. Podevin, P; Correia, L; Montet, JC; Conti, F; Chereau, C; Calmus, Y; Poupon, R
    Effects of bile salts and aliphatic ionic surfactants on human lymphocyte proliferation
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    
    P. Podevin et al., "Effects of bile salts and aliphatic ionic surfactants on human lymphocyte proliferation", EUR J CL IN, 31(4), 2001, pp. 367-373
12. Peoc'h, K; Dubel, L; Chazouilleres, O; Ocwieja, T; Duron, F; Poupon, R; Johanet, C
    Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus - Related infection
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    K. Peoc'h et al., "Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus - Related infection", AM J GASTRO, 96(10), 2001, pp. 2978-2983
13. Poupon, R; Poupon, RE
    Treatment of primary biliary cirrhosis
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    R. Poupon e R.E. Poupon, "Treatment of primary biliary cirrhosis", BEST PR RES, 14(4), 2000, pp. 615-628
14. Charrueau, C; Blonde-Cynober, F; Coudray-Lucas, C; Poupon, R; Chaumeil, JC; Hannoun, L; Cynober, L
    Prevention of proteolysis in cold-stored rat liver by addition of amino acids to the preservation solution
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    
    C. Charrueau et al., "Prevention of proteolysis in cold-stored rat liver by addition of amino acids to the preservation solution", J GASTR HEP, 15(10), 2000, pp. 1199-1204
15. Biour, M; Poupon, R; Grange, JD; Chazouilleres, O
    Drug-induced liver injury. Thirteenth updated edition of the bibliographicdatabase of drug-related liver injuries and related drugs
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    
    M. Biour et al., "Drug-induced liver injury. Thirteenth updated edition of the bibliographicdatabase of drug-related liver injuries and related drugs", GASTRO CL B, 24(11), 2000, pp. 1052-1091
16. Corpechot, C; Carrat, F; Bonnand, AM; Poupon, RE; Poupon, R
    The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
    HEPATOLOGY
    
    C. Corpechot et al., "The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis", HEPATOLOGY, 32(6), 2000, pp. 1196-1199
17. Corpechot, C; Barbu, V; Chazouilleres, O; Poupon, R
    Fetal microchimerism in primary biliary cirrhosis
    JOURNAL OF HEPATOLOGY
    
    C. Corpechot et al., "Fetal microchimerism in primary biliary cirrhosis", J HEPATOL, 33(5), 2000, pp. 696-700
18. Neveux, N; De Bandt, JP; Fattal, E; Hannoun, L; Poupon, R; Chaumeil, JC; Delattre, J; Cynober, LA
    Cold preservation injury in rat liver: effect of liposomally-entrapped adenosine triphosphate
    JOURNAL OF HEPATOLOGY
    
    N. Neveux et al., "Cold preservation injury in rat liver: effect of liposomally-entrapped adenosine triphosphate", J HEPATOL, 33(1), 2000, pp. 68-75
19. Guechot, J; Serfaty, L; Bonnand, AM; Chazouilleres, O; Poupon, RE; Poupon, R
    Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis
    JOURNAL OF HEPATOLOGY
    
    J. Guechot et al., "Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis", J HEPATOL, 32(3), 2000, pp. 447-452
20. Poupon, R
    Management of primary biliary cirrhosis resistant to ursodeoxycholic acid therapy
    JOURNAL OF HEPATOLOGY
    
    R. Poupon, "Management of primary biliary cirrhosis resistant to ursodeoxycholic acid therapy", J HEPATOL, 32, 2000, pp. 19-20
21. Poupon, R; Chazouilleres, O; Poupon, RE
    Chronic cholestatic diseases
    JOURNAL OF HEPATOLOGY
    
    R. Poupon et al., "Chronic cholestatic diseases", J HEPATOL, 32, 2000, pp. 129-140
22. Lindor, KD; Poupon, R; Poupon, R; Heathcote, EJ; Therneau, T
    Ursodeoxycholic acid for primary biliary cirrhosis
    LANCET
    
    K.D. Lindor et al., "Ursodeoxycholic acid for primary biliary cirrhosis", LANCET, 355(9204), 2000, pp. 657-658
23. Poupon, RE; Bonnand, AM; Queneau, PE; Trepo, C; Zarski, JP; Vetter, D; Raabe, JJ; Thieffin, G; Larrey, D; Grange, JD; Capron, JP; Serfaty, L; Chretien, Y; Girardin, MFS; Mathiex-Fortunet, H; Zafrani, ES; Guechot, J; Beuers, U; Paumgartner, G; Poupon, R
    Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferon
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    
    R.E. Poupon et al., "Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferon", SC J GASTR, 35(6), 2000, pp. 642-649
24. Kinnman, N; Hultcrantz, R; Barbu, V; Rey, C; Wendum, D; Poupon, R; Housset, C
    PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury
    LABORATORY INVESTIGATION
    
    N. Kinnman et al., "PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury", LAB INV, 80(5), 2000, pp. 697-707
25. Rosmorduc, O; Poupon, R; Nion, I; Wendum, D; Feder, J; Bereziat, G; Hermelin, B
    Differential HFE allele expression in hemochromatosis heterozygotes
    GASTROENTEROLOGY
    
    O. Rosmorduc et al., "Differential HFE allele expression in hemochromatosis heterozygotes", GASTROENTY, 119(4), 2000, pp. 1075-1086
26. Benlian, P; Cansier, C; Hennache, G; Khallouf, O; Bayer, P; Duron, F; Carrat, F; Couderc, R; Chazouilleres, O; Bardet, J; Bouchard, P; Poupon, R; Masliah, J; Bereziat, G
    Comparison of a new method for the direct and simultaneous assessment of LDL- and HDL-cholesterol with ultracentrifugation and established methods
    CLINICAL CHEMISTRY
    
    P. Benlian et al., "Comparison of a new method for the direct and simultaneous assessment of LDL- and HDL-cholesterol with ultracentrifugation and established methods", CLIN CHEM, 46(4), 2000, pp. 493-505
27. Gozlan, J; Nion, I; Chazouilleres, O; Chretien, Y; Poupon, R
    Soluble Fas is increased in serum of patients with primary biliary cirrhosis, but is not a useful marker for disease activity
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    J. Gozlan et al., "Soluble Fas is increased in serum of patients with primary biliary cirrhosis, but is not a useful marker for disease activity", AM J GASTRO, 95(11), 2000, pp. 3328-3329
28. Peoc'h, K; Dubel, L; Chazouilleres, O; Ocwieja, T; Duron, F; Poupon, R; Johanet, C
    A new type of antithyroid antibodies in untreated patients with chronic hepatitis C infection
    HEPATOLOGY RESEARCH
    
    K. Peoc'h et al., "A new type of antithyroid antibodies in untreated patients with chronic hepatitis C infection", HEPATOL RES, 14(1), 1999, pp. 78-83
29. Heathcote, EJ; Stone, J; Cauch-Dudek, K; Poupon, R; Chazouilleres, O; Lindor, KD; Petz, J; Dickson, ER; Poupon, RE
    Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis
    LIVER TRANSPLANTATION AND SURGERY
    
    E.J. Heathcote et al., "Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis", LIVER TR S, 5(4), 1999, pp. 269-274
30. Podevin, P; Poupon, R
    A role for bile acids in modulating gene expression
    M S-MEDECINE SCIENCES
    
    P. Podevin e R. Poupon, "A role for bile acids in modulating gene expression", M S-MED SCI, 15(12), 1999, pp. 1472-1475
31. Rosmorduc, O; Paterlini, P; Poupon, R; Brechot, C
    Hepatitis viruses and hepatocellular carcinoma.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    
    O. Rosmorduc et al., "Hepatitis viruses and hepatocellular carcinoma.", GASTRO CL B, 23(3), 1999, pp. 363-375
32. Biour, M; Poupon, R; Grange, JD; Chazouilleres, O; Jaillon, P
    Drug-induced liver injury. Twelfth updated edition of the bibliographic database of liver injuries and related drugs
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    
    M. Biour et al., "Drug-induced liver injury. Twelfth updated edition of the bibliographic database of liver injuries and related drugs", GASTRO CL B, 23(12), 1999, pp. 1310-1352
33. Lakehal, F; Wendum, D; Barbu, V; Becquemont, L; Poupon, R; Balladur, P; Hannoun, L; Ballet, F; Beaune, PH; Housset, C
    Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium
    HEPATOLOGY
    
    F. Lakehal et al., "Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium", HEPATOLOGY, 30(6), 1999, pp. 1498-1506
34. Poupon, RE; Bonnand, AM; Chretien, Y; Poupon, R
    Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis
    HEPATOLOGY
    
    R.E. Poupon et al., "Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis", HEPATOLOGY, 29(6), 1999, pp. 1668-1671
35. Podevin, P; Rosmorduc, O; Conti, F; Calmus, Y; Meier, PJ; Poupon, R
    Bile acids modulate the interferon signalling pathway
    HEPATOLOGY
    
    P. Podevin et al., "Bile acids modulate the interferon signalling pathway", HEPATOLOGY, 29(6), 1999, pp. 1840-1847
36. Degott, C; Zafrani, ES; Callard, P; Balkau, B; Poupon, RE; Poupon, R
    Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression
    HEPATOLOGY
    
    C. Degott et al., "Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression", HEPATOLOGY, 29(4), 1999, pp. 1007-1012
37. Pol, S; Couzigou, P; Bourliere, M; Abergel, A; Combis, JM; Larrey, D; Tran, A; Moussalli, J; Poupon, R; Berthelot, P; Brechot, C
    A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment
    JOURNAL OF HEPATOLOGY
    
    S. Pol et al., "A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment", J HEPATOL, 31(1), 1999, pp. 1-7
38. De Bandt, JP; Lasnier, E; Rey, C; Coudray-Lucas, C; Poupon, R; Giboudeau, J; Cynober, LA
    Effects of amino acids on bile acid-dependent and independent bile flow inthe isolated perfused rat liver
    JOURNAL OF HEPATOLOGY
    
    J.P. De Bandt et al., "Effects of amino acids on bile acid-dependent and independent bile flow inthe isolated perfused rat liver", J HEPATOL, 30(5), 1999, pp. 843-849
39. Poupon, R; Chazouilleres, O; Balkau, B; Poupon, RE
    Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis
    JOURNAL OF HEPATOLOGY
    
    R. Poupon et al., "Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis", J HEPATOL, 30(3), 1999, pp. 408-412
40. Blanc, MC; Housset, C; Lasnier, E; Rey, C; Capeau, J; Giboudeau, J; Poupon, R; Vaudourdolle, M
    Direct cytotoxicity of hypoxia-reoxygenation towards sinusoidal endothelial cells in the rat
    LIVER
    
    M.C. Blanc et al., "Direct cytotoxicity of hypoxia-reoxygenation towards sinusoidal endothelial cells in the rat", LIVER, 19(1), 1999, pp. 42-49
41. Rosmorduc, O; Wendum, D; Corpechot, C; Galy, B; Sebbagh, N; Raleigh, J; Housset, C; Poupon, R
    Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis
    AMERICAN JOURNAL OF PATHOLOGY
    
    O. Rosmorduc et al., "Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis", AM J PATH, 155(4), 1999, pp. 1065-1073
42. Biour, M; Poupon, R; Grange, JD; Chazouilleres, O; Jaillon, P
    Drug-induced liver injury. Eleventh updated edition of the bibliographic data base of liver injuries and related drugs
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    
    M. Biour et al., "Drug-induced liver injury. Eleventh updated edition of the bibliographic data base of liver injuries and related drugs", GASTRO CL B, 22(12), 1998, pp. 1004-1044
43. CHARRUEAU C; SAVIER E; BLONDECYNOBER F; COUDRAYLUCAS C; POUPON R; GIBOUDEAU J; CHAUMEIL JC; HANNOUN L; CYNOBER L
    EFFECT OF 2 STORAGE SOLUTIONS ON PROTEOLYSIS IN ISOLATED RAT LIVERS
    International journal of pharmaceutics
    
    C. Charrueau et al., "EFFECT OF 2 STORAGE SOLUTIONS ON PROTEOLYSIS IN ISOLATED RAT LIVERS", International journal of pharmaceutics, 170(2), 1998, pp. 257-264
44. SERFATY L; COSTAGLIOLA D; WENDUM D; PICARD O; MEYOHAS MC; GIRARD PM; LEBAS J; DELAMARE DC; POUPON R; HOUSSET C
    DOES HIV-INFECTION AGGRAVATE CHRONIC HEPATITIS-C IN IV DRUG-USERS - ACASE-CONTROL STUDY
    Hepatology
    
    L. Serfaty et al., "DOES HIV-INFECTION AGGRAVATE CHRONIC HEPATITIS-C IN IV DRUG-USERS - ACASE-CONTROL STUDY", Hepatology, 28(4), 1998, pp. 1199-1199
45. KINNMAN N; FOUASSIER L; HULTCRANTZ R; REY C; POUPON R; HOUSSET C
    INTRAHEPATIC BILE-DUCTS FROM CHOLESTATIC RATS INDUCE HEPATIC STELLATECELL-MIGRATION
    Hepatology
    
    N. Kinnman et al., "INTRAHEPATIC BILE-DUCTS FROM CHOLESTATIC RATS INDUCE HEPATIC STELLATECELL-MIGRATION", Hepatology, 28(4), 1998, pp. 1405-1405
46. ROSMORDUC O; POUPON R; BEREZIAT G; CLAUSER E; HERMELIN B
    DIFFERENTIAL ALLELE EXPRESSION OF HFE TRANSCRIPTS IN HETEROZYGOUS PATIENTS AND ITS INFLUENCE UPON IRON OVERLOAD
    Hepatology
    
    O. Rosmorduc et al., "DIFFERENTIAL ALLELE EXPRESSION OF HFE TRANSCRIPTS IN HETEROZYGOUS PATIENTS AND ITS INFLUENCE UPON IRON OVERLOAD", Hepatology, 28(4), 1998, pp. 1456-1456
47. DEGOTT C; ZAFRANI ES; CALLARD P; POUPON RE; POUPON R
    SEVERITY OF LYMPHOCYTIC PIECEMEAL NECROSIS AND LOBULAR INFLAMMATION ARE DETERMINANTS OF FIBROSIS PROCESSION IN UDCA-TREATED PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS (PBC)
    Hepatology
    
    C. Degott et al., "SEVERITY OF LYMPHOCYTIC PIECEMEAL NECROSIS AND LOBULAR INFLAMMATION ARE DETERMINANTS OF FIBROSIS PROCESSION IN UDCA-TREATED PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS (PBC)", Hepatology, 28(4), 1998, pp. 1526-1526
48. SERFATY L; LORIA A; CHAZOUILLERES O; CHRETIEN Y; POUPON RE; POUPON R
    PREVALENCE AND COLORECTAL CHARACTERISTICS OF COLORECTAL ADENOMAS IN PATIENTS TREATED WITH URSODESOXYCHOLIC ACID FOR PRIMARY BILIARY-CIRRHOSIS - A CASE-CONTROL STUDY
    Hepatology
    
    L. Serfaty et al., "PREVALENCE AND COLORECTAL CHARACTERISTICS OF COLORECTAL ADENOMAS IN PATIENTS TREATED WITH URSODESOXYCHOLIC ACID FOR PRIMARY BILIARY-CIRRHOSIS - A CASE-CONTROL STUDY", Hepatology, 28(4), 1998, pp. 1527-1527
49. CHAZOUILLERES O; POUPON R; BONNAND AM; POUPON RE
    PREGNANCY AND URSODEOXYCHOLIC ACID (UDCA) TREATMENT INDUCE REMISSION OF PRIMARY BILIARY-CIRRHOSIS (PBC)
    Hepatology
    
    O. Chazouilleres et al., "PREGNANCY AND URSODEOXYCHOLIC ACID (UDCA) TREATMENT INDUCE REMISSION OF PRIMARY BILIARY-CIRRHOSIS (PBC)", Hepatology, 28(4), 1998, pp. 1530-1530
50. PEOCH K; DUBEL L; CHAZOUILLERES O; OCWIEIA T; DURON F; POUPON R; JOHANET C
    A NEW-TYPE OF THYROID ANTIMICROSOMAL ANTIBODIES IN UNTREATED PATIENTSWITH CHRONIC HEPATITIS-C INFECTION
    Hepatology
    
    K. Peoch et al., "A NEW-TYPE OF THYROID ANTIMICROSOMAL ANTIBODIES IN UNTREATED PATIENTSWITH CHRONIC HEPATITIS-C INFECTION", Hepatology, 28(4), 1998, pp. 2058-2058
51. CHAZOUILLERES O; WENDUM D; SERFATY L; MONTEMBAULT S; ROSMORDUC O; POUPON R
    PRIMARY BILIARY-CIRRHOSIS AUTOIMMUNE HEPATITIS OVERLAP SYNDROME - CLINICAL-FEATURES AND RESPONSE TO THERAPY
    Hepatology
    
    O. Chazouilleres et al., "PRIMARY BILIARY-CIRRHOSIS AUTOIMMUNE HEPATITIS OVERLAP SYNDROME - CLINICAL-FEATURES AND RESPONSE TO THERAPY", Hepatology, 28(2), 1998, pp. 296-301
52. SERFATY L; AUMAITRE H; CHAZOUILLERES O; BONNAND AM; ROSMORDUC O; POUPON RE; POUPON R
    DETERMINANTS OF OUTCOME OF COMPENSATED HEPATITIS-C VIRUS-RELATED CIRRHOSIS
    Hepatology
    
    L. Serfaty et al., "DETERMINANTS OF OUTCOME OF COMPENSATED HEPATITIS-C VIRUS-RELATED CIRRHOSIS", Hepatology, 27(5), 1998, pp. 1435-1440
53. FOUASSIER L; CHINET T; ROBERT B; CARAYON A; BALLADUR P; MERGEY M; PAUL A; POUPON R; CAPEAU J; BARBU V; HOUSSET C
    ENDOTHELIN-1 IS SYNTHESIZED AND INHIBITS CYCLIC ADENOSINE MONOPHOSPHATE-DEPENDENT ANION SECRETION BY AN AUTOCRINE PARACRINE MECHANISM IN GALLBLADDER EPITHELIAL-CELLS/
    The Journal of clinical investigation
    
    L. Fouassier et al., "ENDOTHELIN-1 IS SYNTHESIZED AND INHIBITS CYCLIC ADENOSINE MONOPHOSPHATE-DEPENDENT ANION SECRETION BY AN AUTOCRINE PARACRINE MECHANISM IN GALLBLADDER EPITHELIAL-CELLS/", The Journal of clinical investigation, 101(12), 1998, pp. 2881-2888
54. LINDOR KD; PETZ J; HEATHCOTE EJ; CHAZOUILLERES O; CAUCHDUDEK K; POUPON RE; POUPON R
    CAUSES OF MORTALITY IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS TREATED WITH URSODIOL
    Gastroenterology
    
    K.D. Lindor et al., "CAUSES OF MORTALITY IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS TREATED WITH URSODIOL", Gastroenterology, 114(4), 1998, pp. 381-381
55. DHUMEAUX D; DOFFOEL M; BEDOSSA P; BIGARD MA; BISMUTH H; CACOUB P; CARPENTIER F; COUROUCE AM; DUROCHER A; GALMICHE JP; GOUDEAU A; HILLON P; MARCELLIN P; OULDAOUDIA V; PHAM BN; RAGUIN G; AUBREGE A; ASSIE P; CARO D; CHAVANET P; COLOMB M; DUCROTTE P; FRANCO D; GORDIN J; GOUILLOUD S; HAMMEL JP; HUGUET C; PARIENTE A; REVEL M; RICHARD S; SALAMON R; WORONOFFLEMSI MC; BRECHOT C; BRISSOT P; COUZIGOU P; DEGOS F; DESENCLOS JC; DEUGNIER Y; DURAND JM; LARREY D; LUNELFABIANI F; MARCELLIN P; MIGUET JM; MOATTI JP; PASCAL JP; PAWLOTSKY JM; POUPON R; POYNARD T; TREPO C; ZARSKI JP; MUSSET L; PEREZ P; TRAN A; SERFATY L; PAYEN JL; OUZAN D
    CONSENSUS CONFERENCE ON SCREENING AND TRE ATMENT OF HEPATITIS-C
    La Presse medicale
    
    D. Dhumeaux et al., "CONSENSUS CONFERENCE ON SCREENING AND TRE ATMENT OF HEPATITIS-C", La Presse medicale, 26(3), 1997, pp. 126-128
56. POUPON R
    FOLLOW-UP OF NON-TREATED HEPATITIS-C
    Gastroenterologie clinique et biologique
    
    R. Poupon, "FOLLOW-UP OF NON-TREATED HEPATITIS-C", Gastroenterologie clinique et biologique, 21(1BIS), 1997, pp. 96-98
57. BIOUR M; POUPON R; GRANGE JD; CHAZOUILLERES O; LEVY VG; JAILLON P
    DRUG-INDUCED LIVER-INJURY - 10TH UPDATED EDITION OF THE BIBLIOGRAPHICDATABASE OF LIVER INJURIES AND RELATED DRUGS
    Gastroenterologie clinique et biologique
    
    M. Biour et al., "DRUG-INDUCED LIVER-INJURY - 10TH UPDATED EDITION OF THE BIBLIOGRAPHICDATABASE OF LIVER INJURIES AND RELATED DRUGS", Gastroenterologie clinique et biologique, 21(10), 1997, pp. 660-696
58. MONTEMBAULT S; SERFATY L; POIROT JL; WENDUM D; PENNA C; POUPON R
    SEVERE INFECTION WITH FASCIOLA-HEPATICA A S THE CAUSE OF HEMORRHAGIC ASCITES
    Gastroenterologie clinique et biologique
    
    S. Montembault et al., "SEVERE INFECTION WITH FASCIOLA-HEPATICA A S THE CAUSE OF HEMORRHAGIC ASCITES", Gastroenterologie clinique et biologique, 21(10), 1997, pp. 785-788
59. BARBU V; BONNAND AM; HILLAIRE S; COSTE T; CHAZOUILLERES O; GUGENHEIM J; BOUCHER E; POUPON R; POUPON RE
    CIRCULATING ALBUMIN MESSENGER-RNA IN HEPATOCELLULAR-CARCINOMA - RESULTS OF A MULTICENTER PROSPECTIVE-STUDY
    Hepatology
    
    V. Barbu et al., "CIRCULATING ALBUMIN MESSENGER-RNA IN HEPATOCELLULAR-CARCINOMA - RESULTS OF A MULTICENTER PROSPECTIVE-STUDY", Hepatology, 26(5), 1997, pp. 1171-1175
60. POUPON RE; BONNAND AM; CHRETIEN Y; POUPON R
    LONG-TERM SURVIVAL IN URSODEOXYCHOLIC ACID-TREATED PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS
    Hepatology
    
    R.E. Poupon et al., "LONG-TERM SURVIVAL IN URSODEOXYCHOLIC ACID-TREATED PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS", Hepatology, 26(4), 1997, pp. 936-936
61. LAKEHAL F; WENDUM D; BEAUNE P; BALLET F; POUPON R; HOUSSET C
    HETEROGENEOUS EXPRESSION OF DRUG-METABOLIZING-ENZYMES IN HUMAN BILIARY EPITHELIAL-CELLS
    Hepatology
    
    F. Lakehal et al., "HETEROGENEOUS EXPRESSION OF DRUG-METABOLIZING-ENZYMES IN HUMAN BILIARY EPITHELIAL-CELLS", Hepatology, 26(4), 1997, pp. 1075-1075
62. ROSMORDUC O; WENDUM D; GALY B; SEBBAG N; REY C; POUPON R
    CHOLESTATIC LIVER-INJURY INDUCES OVEREXPRESSION OF ANGIOGENIC FACTORSVEGF AND BFGF
    Hepatology
    
    O. Rosmorduc et al., "CHOLESTATIC LIVER-INJURY INDUCES OVEREXPRESSION OF ANGIOGENIC FACTORSVEGF AND BFGF", Hepatology, 26(4), 1997, pp. 1085-1085
63. POUPON RE; BONNAND AM; HEATHCOTE EI; LINDOR KD; POUPON R
    PROGNOSTIC FACTORS IN URSODEOXYCHOLIC ACID-TREATED PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS
    Hepatology
    
    R.E. Poupon et al., "PROGNOSTIC FACTORS IN URSODEOXYCHOLIC ACID-TREATED PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS", Hepatology, 26(4), 1997, pp. 1086-1086
64. POUPON R; CHRETIEN Y; CHAZOUILLERES O; BONNARD AM; POUPON RE
    BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID (UDCA) PREDICTS PROGRESSION OF PRIMARY BILIARY-CIRRHOSIS
    Hepatology
    
    R. Poupon et al., "BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID (UDCA) PREDICTS PROGRESSION OF PRIMARY BILIARY-CIRRHOSIS", Hepatology, 26(4), 1997, pp. 1087-1087
65. POUPON R; GORIA O; CHAZOUILLERES O; CHRETIEN Y; BONNAND AM; POUPON RE
    GLUCOCORTICOIDS IN COMBINATION WITH URSODEOXYCHOLIC ACID (UDCA) FOR PRIMARY BILIARY-CIRRHOSIS RESISTANT TO UDCA ALONE
    Hepatology
    
    R. Poupon et al., "GLUCOCORTICOIDS IN COMBINATION WITH URSODEOXYCHOLIC ACID (UDCA) FOR PRIMARY BILIARY-CIRRHOSIS RESISTANT TO UDCA ALONE", Hepatology, 26(4), 1997, pp. 1088-1088
66. CASTELNAU C; ZARSKI JP; POUPON R; METREAU JM; HACHEMANE S; TREPO C; COUZIGOU P; TRAN A; CAUSSE X; BETTAN L; GRANGER D; CAPRON JP; CALES P; GAUTHIER A; LEGER E; DEPAILLETTE ED; MARCELLIN P
    RANDOMIZED CONTROLLED TRIAL OF POLYADENUR (POLYA POLYU) FOLLOWED BY ALPHA-INTERFERON VERSUS ALPHA-INTERFERON ALONE IN PATIENTS WITH CHRONICHEPATITIS-B
    Hepatology
    
    C. Castelnau et al., "RANDOMIZED CONTROLLED TRIAL OF POLYADENUR (POLYA POLYU) FOLLOWED BY ALPHA-INTERFERON VERSUS ALPHA-INTERFERON ALONE IN PATIENTS WITH CHRONICHEPATITIS-B", Hepatology, 26(4), 1997, pp. 1186-1186
67. HEATHCOTE EJ; CAUCHDUDEK K; STONE J; POUPON R; CHAZOUILLERES O; LINDOR KD; PETZ J; DICKSON ER; POUPON RE
    THE EFFECT OF URSODIOL THERAPY PRIOR TO TRANSPLANTATION ON OUTCOME OFLIVER-TRANSPLANTATION IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS
    Hepatology
    
    E.J. Heathcote et al., "THE EFFECT OF URSODIOL THERAPY PRIOR TO TRANSPLANTATION ON OUTCOME OFLIVER-TRANSPLANTATION IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS", Hepatology, 26(4), 1997, pp. 1239-1239
68. CORREIA L; PODEVIN P; BORDERIE D; CONTI F; POUPON R; CALMUS Y
    INHIBITION OF THE HUMORAL IMMUNE-RESPONSE BY BILE-ACIDS IS PROLIFERATION-DEPENDENT
    Hepatology
    
    L. Correia et al., "INHIBITION OF THE HUMORAL IMMUNE-RESPONSE BY BILE-ACIDS IS PROLIFERATION-DEPENDENT", Hepatology, 26(4), 1997, pp. 1271-1271
69. SERFATY L; CHAZOUILLERES O; POUJOLROBERT A; MORANDJOUBERT L; DUBOIS C; CHRETIEN Y; POUPON RE; PETIT JC; POUPON R
    RISK-FACTORS FOR CIRRHOSIS IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION - RESULTS OF A CASE-CONTROL STUDY
    Hepatology
    
    L. Serfaty et al., "RISK-FACTORS FOR CIRRHOSIS IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION - RESULTS OF A CASE-CONTROL STUDY", Hepatology, 26(3), 1997, pp. 776-779
70. ROUDOTTHORAVAL F; BASTIE A; PAWLOTSKY JM; DHUMEAUX D; AUDIGIER JC; BARBARE JC; BAUDET JG; BEAUGRAND M; BERTHELOT P; BRECHOT C; POL S; CATTAN D; BETTAN L; CHAPUT JC; COUZIGOU P; DAO MT; DENIS J; DOFFOEL M; DRUCKER J; ERLINGER S; MARCELLIN P; ETIENNE JP; BUFFET C; LAURENTPUIG P; FILOCHE B; GAUCHER P; GAUTHIER A; DELREZ R; INK O; METMAN E; BACQ Y; MICHEL H; LARREY D; MIGUET JP; BRESSONHADNI S; MORICHAUBEAUCHANT M; OPOLON P; POYNARD T; PASCAL JP; PAYEN JL; POUPON R; SERFATY L; SONDAG D; TERRIS G; TREPO C; AHMED SNS; WAGNER JC; ZARSKI JP; MAYNARD M
    EPIDEMIOLOGIC FACTORS AFFECTING THE SEVERITY OF HEPATITIS-C VIRUS-RELATED LIVER-DISEASE - A FRENCH SURVEY OF 6,664 PATIENTS
    Hepatology
    
    F. Roudotthoraval et al., "EPIDEMIOLOGIC FACTORS AFFECTING THE SEVERITY OF HEPATITIS-C VIRUS-RELATED LIVER-DISEASE - A FRENCH SURVEY OF 6,664 PATIENTS", Hepatology, 26(2), 1997, pp. 485-490
71. CABANE J; CHAZOUILLERES O; KARSENTY P; LAGIER A; POUPON R; IMBERT JC
    PRIMARY ANTIPHOSPHOLIPID SYNDROME
    La Revue de medecine interne
    
    J. Cabane et al., "PRIMARY ANTIPHOSPHOLIPID SYNDROME", La Revue de medecine interne, 18, 1997, pp. 357-358
72. PODEVIN P; GUECHOT J; SERFATY L; MONRANDJOUBERT L; VEYRUNES C; BONNEFIS MT; POUPON R
    EVIDENCE FOR A DEFICIENCY OF INTERFERON RESPONSE IN MONONUCLEAR-CELLSFROM HEPATITIS-C VIREMIC PATIENTS
    Journal of hepatology
    
    P. Podevin et al., "EVIDENCE FOR A DEFICIENCY OF INTERFERON RESPONSE IN MONONUCLEAR-CELLSFROM HEPATITIS-C VIREMIC PATIENTS", Journal of hepatology, 27(2), 1997, pp. 265-271
73. POUPON R; SERFATY L
    PROPHYLAXIS AND TREATMENT OF HEPATITIS-C
    Annales de Gastroenterologie et d'Hepatologie
    
    R. Poupon e L. Serfaty, "PROPHYLAXIS AND TREATMENT OF HEPATITIS-C", Annales de Gastroenterologie et d'Hepatologie, 33(1), 1997, pp. 34-38
74. GALMICHE JP; AUBREGE A; ASSIE P; CARO D; CHAVANET P; COLOMB M; DUCROTTE P; FRANCO D; GORDIN J; GOUILLOUD S; HAMMEL JP; HUGUET C; PARIENTE A; REVEL M; RICHARD S; SALAMON R; WORONOFFLEMSI MC; BRECHOT C; BRISSOT P; COUZIGOU P; DEGOS F; DESENCLOS JC; DEUGNIER Y; DURAND JM; LARREY D; LUNELFABIANI F; MARCELLIN P; MIGUET JP; MOATTI JP; PASCAL JP; PAWLOTSKY JM; POUPON R; POYNARD T; TREPO C; ZARSKI JP; MUSSET L; PEREZ P; TRAN A; SERFATY L; PAYEN JL; OUZAN D
    HEPATITIS-C - SCREENING AND MANAGEMENT
    La Semaine des hopitaux de Paris
    
    J.P. Galmiche et al., "HEPATITIS-C - SCREENING AND MANAGEMENT", La Semaine des hopitaux de Paris, 73(13-14), 1997, pp. 393-398
75. POUPON RE; LINDOR KD; CAUCHDUDEK K; DICKSON ER; POUPON R; HEATHCOTE EJ
    COMBINED ANALYSIS OF RANDOMIZED CONTROLLED TRIALS OF URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS
    Gastroenterology
    
    R.E. Poupon et al., "COMBINED ANALYSIS OF RANDOMIZED CONTROLLED TRIALS OF URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS", Gastroenterology, 113(3), 1997, pp. 884-890
76. PODEVIN P; BLANC MC; VAUBOURDOLLE M; VEYRUNES C; BONNEFIS MT; POUPON R
    BILE-ACID INHIBITION OF INTERFERON ACTIVITY IN HUMAN-LYMPHOCYTES - NOEVIDENCE OF OXIDATIVE STRESS
    European journal of clinical investigation
    
    P. Podevin et al., "BILE-ACID INHIBITION OF INTERFERON ACTIVITY IN HUMAN-LYMPHOCYTES - NOEVIDENCE OF OXIDATIVE STRESS", European journal of clinical investigation, 27(6), 1997, pp. 491-496
77. BIOUR M; POUPON R; GRANGE JD; CHAZOUILLERES O; LEVY VG; BODIN F; CHEYMOL G
    DRUG-INDUCED LIVER-INJURY - 9TH UPDATED E DITION OF THE BIBLIOGRAPHICDATABASE OF LIVER INJURIES AND RELATED DRUGS
    Gastroenterologie clinique et biologique
    
    M. Biour et al., "DRUG-INDUCED LIVER-INJURY - 9TH UPDATED E DITION OF THE BIBLIOGRAPHICDATABASE OF LIVER INJURIES AND RELATED DRUGS", Gastroenterologie clinique et biologique, 20(10), 1996, pp. 744-779
78. POUPON RE; HUET PM; POUPON R; BONNAND AM; VANNHIEU JT; ZAFRANI ES; BRESSONHADNI S; MIGUET JP; MATHIEUCHANDELIER C; DOFFOEL M; VETTER D; ZARSKI JP; PARIENTE EA; CAPRON JP; GRANGE JD; DAVID A; DEGOS F; BOUNIN M; DHUMEAUX D; ZAFRANI ES; MYARA A; GUECHOT J
    A RANDOMIZED TRIAL COMPARING COLCHICINE AND URSODEOXYCHOLIC ACID COMBINATION TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS
    Hepatology
    
    R.E. Poupon et al., "A RANDOMIZED TRIAL COMPARING COLCHICINE AND URSODEOXYCHOLIC ACID COMBINATION TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS", Hepatology, 24(5), 1996, pp. 1098-1103
79. SERFATY L; POUJOL A; CHAZOUILLERES O; DUBOIS C; MORANDJOUBERT L; CHRETIEN Y; POUPON RE; POUPON R
    RISK-FACTORS FOR LIVER-CIRRHOSIS OCCURRENCE IN PATIENTS WITH CHRONIC HCV INFECTION - A CASE-CONTROL STUDY
    Hepatology
    
    L. Serfaty et al., "RISK-FACTORS FOR LIVER-CIRRHOSIS OCCURRENCE IN PATIENTS WITH CHRONIC HCV INFECTION - A CASE-CONTROL STUDY", Hepatology, 24(4), 1996, pp. 98-98
80. CHAZOUILLERES O; MONTEBAULT S; POUPON R
    PRIMARY BILIARY-CIRRHOSIS (PBC) AUTOIMMUNE HEPATITIS (AH) OVERLAP SYNDROME - CLINICAL-FEATURES AND RESPONSE TO THERAPY
    Hepatology
    
    O. Chazouilleres et al., "PRIMARY BILIARY-CIRRHOSIS (PBC) AUTOIMMUNE HEPATITIS (AH) OVERLAP SYNDROME - CLINICAL-FEATURES AND RESPONSE TO THERAPY", Hepatology, 24(4), 1996, pp. 163-163
81. SERFATY L; AUMAITRE H; CHAZOUILLERES O; MORANDJOUBERT L; PETIT JC; POUPON R
    LONG-TERM FOLLOW-UP OF HCV COMPENSATED CIRRHOSIS
    Hepatology
    
    L. Serfaty et al., "LONG-TERM FOLLOW-UP OF HCV COMPENSATED CIRRHOSIS", Hepatology, 24(4), 1996, pp. 501-501
82. ROSMORDUC O; WENDUM D; GALY B; HUEZ I; WEBER A; PRAT H; DESAINTMAUR PP; POUPON R
    EXPRESSION OF ANGIOGENIC FACTORS BFGF ET VEGF DURING LIVER CARCINOGENESIS IN A TRANSGENIC MICE MODEL
    Hepatology
    
    O. Rosmorduc et al., "EXPRESSION OF ANGIOGENIC FACTORS BFGF ET VEGF DURING LIVER CARCINOGENESIS IN A TRANSGENIC MICE MODEL", Hepatology, 24(4), 1996, pp. 857-857
83. ROSMORDUC O; WENDUM D; GALY B; HUEZ I; PRAT H; DESAINTMAUR PP; POUPON R
    EXPRESSION OF THE ANGIOGENIC FACTORS BFGF AND VEGF IN HUMAN CIRRHOSISAND HEPATOCARCINOMA
    Hepatology
    
    O. Rosmorduc et al., "EXPRESSION OF THE ANGIOGENIC FACTORS BFGF AND VEGF IN HUMAN CIRRHOSISAND HEPATOCARCINOMA", Hepatology, 24(4), 1996, pp. 858-858
84. GUECHOT J; SERFATY L; POUPON R; GIBOUDEAU J
    PROGNOSTIC VALUE OF SERUM HYALURONAN LEVELS INPATIENTS WITH HCV COMPENSATED CIRRHOSIS
    Hepatology
    
    J. Guechot et al., "PROGNOSTIC VALUE OF SERUM HYALURONAN LEVELS INPATIENTS WITH HCV COMPENSATED CIRRHOSIS", Hepatology, 24(4), 1996, pp. 1067-1067
85. BONNAND AM; POUPON R; QUENEAU PE; TREPO C; COHARD M; VETTER D; RAABE JJ; LAMEY D; GRANGE JD; CAPRON JP; SERFATY L; CHRETIEN Y; SAINTMARCGIRARDIN MF; MATHIEXFORTUNET H; ZAFRANI ES; POUPON RE
    INTERFERON-ALFA AND URSODEOXYCHOLIC ACID COMBINATION VERSUS INTERFERON ALONE IN THE TREATMENT OF CHRONIC HEPATITIS-C - RESULTS OF A RANDOMIZED TRIAL
    Hepatology
    
    A.M. Bonnand et al., "INTERFERON-ALFA AND URSODEOXYCHOLIC ACID COMBINATION VERSUS INTERFERON ALONE IN THE TREATMENT OF CHRONIC HEPATITIS-C - RESULTS OF A RANDOMIZED TRIAL", Hepatology, 24(4), 1996, pp. 1107-1107
86. GORIA O; MARATRAT M; REY C; BALLET F; POUPON R; HOUSSET C
    CHOLESTATIC LIVER-INJURY INDUCES A RAPID INCREASE IN HEPATIC STELLATECELLS PROLIFERATION AND EXPRESSION OF BETA-PDGF-RECEPTOR
    Hepatology
    
    O. Goria et al., "CHOLESTATIC LIVER-INJURY INDUCES A RAPID INCREASE IN HEPATIC STELLATECELLS PROLIFERATION AND EXPRESSION OF BETA-PDGF-RECEPTOR", Hepatology, 24(4), 1996, pp. 1560-1560
87. SERFATY L; PAWLOTSKY JM; GERMANIDIS G; CHAZOUILLERES O; PILON A; POUPON R
    IS GB-VIRUS-C (GBV-C) THE CAUSE OF CRYPTOGENETIC CHRONIC LIVER-DISEASE
    Hepatology
    
    L. Serfaty et al., "IS GB-VIRUS-C (GBV-C) THE CAUSE OF CRYPTOGENETIC CHRONIC LIVER-DISEASE", Hepatology, 24(4), 1996, pp. 1802-1802
88. VAUBOURDOLLE M; CHAZOUILLERES O; LASNIER E; SERFATY L; GIBOUDEAU J; POUPON R
    PLASMA PI-GLUTATHIONE S-TRANSFERASE AS A MARKER OF BILIARY CELL-DAMAGE
    Hepatology
    
    M. Vaubourdolle et al., "PLASMA PI-GLUTATHIONE S-TRANSFERASE AS A MARKER OF BILIARY CELL-DAMAGE", Hepatology, 24(4), 1996, pp. 1868-1868
89. BANDIN O; COURVALIN JC; POUPON R; DUBEL L; HOMBERG JC; JOHANET C
    SPECIFICITY AND SENSITIVITY OF GP210 AUTOANTIBODIES DETECTED USING ANENZYME-LINKED-IMMUNOSORBENT-ASSAY AND A SYNTHETIC POLYPEPTIDE IN THE DIAGNOSIS OF PRIMARY BILIARY-CIRRHOSIS
    Hepatology
    
    O. Bandin et al., "SPECIFICITY AND SENSITIVITY OF GP210 AUTOANTIBODIES DETECTED USING ANENZYME-LINKED-IMMUNOSORBENT-ASSAY AND A SYNTHETIC POLYPEPTIDE IN THE DIAGNOSIS OF PRIMARY BILIARY-CIRRHOSIS", Hepatology, 23(5), 1996, pp. 1020-1024
90. CHAZOUILLERES O; JOHANET C; SERFATY L; CARBONNEL F; SMADJA M; NAUDIN G; DUBEL L; POUPON R
    ANTIACTIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIS-C
    Journal of hepatology
    
    O. Chazouilleres et al., "ANTIACTIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIS-C", Journal of hepatology, 24(4), 1996, pp. 513-513
91. CHAZOUILLERES O; MARTEAU P; HANICHE M; JIAN R; POUPON R
    ILEAL ABSORPTION OF BILE-ACIDS IN PATIENTS WITH CHRONIC CHOLESTASIS -SEHCAT TEST-RESULTS AND EFFECT OF URSODEOXYCHOLIC ACID (UDCA)
    Digestive diseases and sciences
    
    O. Chazouilleres et al., "ILEAL ABSORPTION OF BILE-ACIDS IN PATIENTS WITH CHRONIC CHOLESTASIS -SEHCAT TEST-RESULTS AND EFFECT OF URSODEOXYCHOLIC ACID (UDCA)", Digestive diseases and sciences, 41(12), 1996, pp. 2417-2422
92. CHAZOUILLERES O; VAUBOURDOLLE M; ROBERT A; FOUREL V; BALLADUR P; LARIBI A; GIBOUDEAU J; PARC R; POUPON R; HANNOUN L
    SERUM LEVELS OF ENDOTHELIAL INJURY MARKERS CREATINE KINASE-BB AND SOLUBLE THROMBOMODULIN DURING HUMAN LIVER-TRANSPLANTATION
    Liver
    
    O. Chazouilleres et al., "SERUM LEVELS OF ENDOTHELIAL INJURY MARKERS CREATINE KINASE-BB AND SOLUBLE THROMBOMODULIN DURING HUMAN LIVER-TRANSPLANTATION", Liver, 16(4), 1996, pp. 237-240
93. GRIMBERT S; JOHANET C; BENDJABALLAH F; HOMBERG JC; POUPON R; BEAUGRAND M
    ANTIMITOCHONDRIAL ANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIS-C
    Liver
    
    S. Grimbert et al., "ANTIMITOCHONDRIAL ANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIS-C", Liver, 16(3), 1996, pp. 161-165
94. CLAISE C; JOHANET C; BOUHNIK Y; KAPEL N; HOMBERG JC; POUPON R
    ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES IN AUTOIMMUNE LIVER AND INFLAMMATORY BOWEL DISEASES
    Liver
    
    C. Claise et al., "ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES IN AUTOIMMUNE LIVER AND INFLAMMATORY BOWEL DISEASES", Liver, 16(1), 1996, pp. 28-34
95. AUMAITRE H; CHAZOUILLERES O; SERFATY L; ROBERT A; POUPON R
    VITAMIN-K1 THERAPY FOR HEPATOCELLULAR-CARCINOMA - RESULTS OF A PROSPECTIVE OPEN STUDY
    Gastroenterology
    
    H. Aumaitre et al., "VITAMIN-K1 THERAPY FOR HEPATOCELLULAR-CARCINOMA - RESULTS OF A PROSPECTIVE OPEN STUDY", Gastroenterology, 110(4), 1996, pp. 1145-1145
96. CHAZOUILLERES O; VAUBOURDOLLE M; SABBAH I; SERFATY L; GIBOUDEAU J; POUPON R
    PLASMA-CONCENTRATION OF REDUCED GLUTATHIONE (GSH) AND RESPONSE TO INTERFERON (IFN) IN PATIENTS WITH CHRONIC HEPATITIS-C
    Gastroenterology
    
    O. Chazouilleres et al., "PLASMA-CONCENTRATION OF REDUCED GLUTATHIONE (GSH) AND RESPONSE TO INTERFERON (IFN) IN PATIENTS WITH CHRONIC HEPATITIS-C", Gastroenterology, 110(4), 1996, pp. 1167-1167
97. CHAZOUILLERES O; SERFATY L; DAUCHOT JM; LORIA A; LEGENDRE C; POUPON R
    HOW DO PATIENTS WITH MILD CHRONIC HEPATITIS-C RESPOND TO INTERFERON (IFN) THERAPY
    Gastroenterology
    
    O. Chazouilleres et al., "HOW DO PATIENTS WITH MILD CHRONIC HEPATITIS-C RESPOND TO INTERFERON (IFN) THERAPY", Gastroenterology, 110(4), 1996, pp. 1167-1167
98. VAUBOURDOLLE M; CHAZOUILLERES O; SERFATY L; OKANDZE A; POUPON R; GIBOUDEAU M
    ALPHA-GLUTATHIONE S-TRANSFERASE (ALPHA-GST) PLASMA DETERMINATION IN THE FOLLOW-UP OF INTERFERON THERAPY IN CHRONIC HEPATITIS-C
    Gastroenterology
    
    M. Vaubourdolle et al., "ALPHA-GLUTATHIONE S-TRANSFERASE (ALPHA-GST) PLASMA DETERMINATION IN THE FOLLOW-UP OF INTERFERON THERAPY IN CHRONIC HEPATITIS-C", Gastroenterology, 110(4), 1996, pp. 1353-1353
99. SERFATY L; CHAZOUILLERES O; PAWLOTSKY JM; ANDREANI T; PELLET C; POUPON R
    INTERFERON-ALFA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C AND PERSISTENTLY NORMAL AMINOTRANSFERASE ACTIVITY
    Gastroenterology
    
    L. Serfaty et al., "INTERFERON-ALFA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C AND PERSISTENTLY NORMAL AMINOTRANSFERASE ACTIVITY", Gastroenterology, 110(1), 1996, pp. 291-295
100. AOUAD K; CALMUS Y; NORDLINGER B; MYARA A; WEILL B; POUPON R
     IMMUNOSUPPRESSIVE EFFECTS OF ENDOTOXINS AND BILE-ACIDS IN-VIVO IN THERAT
     European journal of clinical investigation
     
     K. Aouad et al., "IMMUNOSUPPRESSIVE EFFECTS OF ENDOTOXINS AND BILE-ACIDS IN-VIVO IN THERAT", European journal of clinical investigation, 26(1), 1996, pp. 45-48